MOH — authorised 1 September 1977
- Marketing authorisation holder: GD SEARLE LLC
- Status: likely_approved
🇮🇱 Norpace Cr in Israel
MOH authorised Norpace Cr on 1 September 1977
Marketing authorisation
Norpace Cr in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Israel
Frequently asked questions
Is Norpace Cr approved in Israel?
Yes. MOH authorised it on 1 September 1977.
Who is the marketing authorisation holder for Norpace Cr in Israel?
GD SEARLE LLC holds the Israeli marketing authorisation.